Dr. Jeffrey R. Jay, M.D. »

Oruka Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Oruka Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 515k 24.51

More positions owned by Dr. Jeffrey R. Jay, M.D.

Neurogene (NGNE)
Abivax Sa Sponsored Ads (ABVX)
Pliant Therapeutics (PLRX)
Evolus (EOLS)
Miragen Therapeutics (VRDN)
Arcellx Common Stock (ACLX)
Cytokinetics Com New (CYTK)
Kalvista Pharmaceuticals (KALV)
Dynavax Technologies Corp Com New (DVAX)
Context Therapeutics (CNTX)
Zura Bio Class A Ord Shs (ZURA)
Oruka Therapeutics
Merus N V (MRUS)
Olema Pharmaceuticals (OLMA)
Ionis Pharmaceuticals (IONS)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Oruka Therapeutics

Fairmount Funds Management
VR Adviser
Commodore Capital
Perceptive Advisors
Avidity Partners Management
Franklin Resources
Paradigm Biocapital Advisors
Braidwell
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Frazier Life Sciences Management
Redmile Group
Woodline Partners
Affinity Asset Advisors
Driehaus Capital Management

View all funds holding Oruka Therapeutics